Estimating (quality‐adjusted) life‐year losses associated with deaths: With application to COVID‐19 AH Briggs, DA Goldstein, E Kirwin, R Meacock, A Pandya, DJ Vanness, ... Health Economics 30 (3), 699-707, 2021 | 76 | 2021 |
Vaccine rollout strategies: The case for vaccinating essential workers early N Mulberry, P Tupper, E Kirwin, C McCabe, C Colijn PLOS Global Public Health 1 (10), e0000020, 2021 | 60 | 2021 |
A conceptual framework for life-cycle health technology assessment E Kirwin, J Round, K Bond, C McCabe Value in Health 25 (7), 1116-1123, 2022 | 30 | 2022 |
A net benefit approach for the optimal allocation of a covid-19 vaccine E Kirwin, E Rafferty, K Harback, J Round, C McCabe PharmacoEconomics, 1-15, 2021 | 29 | 2021 |
Early initiation of tumor necrosis factor antagonist–based therapy for patients with Crohn’s disease reduces costs compared with late initiation CL Beilman, E Kirwin, C Ma, C McCabe, RN Fedorak, B Halloran Clinical Gastroenterology and Hepatology 17 (8), 1515-1524. e4, 2019 | 19 | 2019 |
Comparative effectiveness and cost-effectiveness analysis of a urine metabolomics test vs. alternative colorectal cancer screening strategies S Barichello, L Deng, KP Ismond, DE Loomes, EM Kirwin, H Wang, ... International Journal of Colorectal Disease 34, 1953-1962, 2019 | 11 | 2019 |
The diagonal approach: A theoretic framework for the economic evaluation of vertical and horizontal interventions in healthcare E Kirwin, R Meacock, J Round, M Sutton Social Science & Medicine 301, 114900, 2022 | 10 | 2022 |
Pandemic Risk Assessment Model (PRAM): a mathematical modeling approach to pandemic influenza planning DC Dover, EM Kirwin, N Hernandez-Ceron, KA Nelson Epidemiology & Infection 144 (16), 3400-3411, 2016 | 8 | 2016 |
Comparing methods to estimate incremental inpatient costs and length of stay due to methicillin-resistant Staphylococcus aureus in Alberta, Canada E Kirwin, M Varughese, D Waldner, K Simmonds, AM Joffe, S Smith BMC Health Services Research 19, 1-8, 2019 | 7 | 2019 |
The risk-based price: incorporating uncertainty and risk attitudes in health technology pricing E Kirwin, M Paulden, C McCabe, J Round, M Sutton, R Meacock SSRN, 2021 | 3 | 2021 |
A systematic review of the accessibility, acceptability, safety, efficiency, clinical effectiveness, and cost-effectiveness of private cataract and orthopedic surgery clinics I Akpinar, E Kirwin, L Tjosvold, D Chojecki, J Round International Journal of Technology Assessment in Health Care 39 (1), e47, 2023 | 1 | 2023 |
Comparative Effectiveness and Cost-Effectiveness Analysis of a Urine Test versus Alternative Colorectal Cancer Screening Strategies: 268 S Barichello, T Nguyen, L Deng, DE Loomes, E Kirwin, H Wang, D Chang, ... Official journal of the American College of Gastroenterology| ACG 113, S153, 2018 | 1 | 2018 |
A103 early initiation of anti-TNF therapy is cost-saving compared to late initiation for patients with Crohn’s disease CL Beilman, E Kirwin, C Ma, C McCabe, R Fedorak, BP Halloran Journal of the Canadian Association of Gastroenterology 1 (suppl_1), 177-178, 2018 | 1 | 2018 |
Early Initiation of Anti-TNF Therapy is Cost-Saving Compared to Late Initiation for Patients with Crohn's Disease CL Beilman, E Kirwin, C Ma, C McCabe, RN Fedorak, BP Halloran Gastroenterology 152 (5), S137, 2017 | 1 | 2017 |
OP47 The Risk-Based Price: Incorporating Uncertainty And Risk Attitudes In Health Technology Pricing E Kirwin, M Paulden, C McCabe, J Round, M Sutton, R Meacock International Journal of Technology Assessment in Health Care 39 (S1), S13-S13, 2023 | | 2023 |
OP46 The Decision Uncertainty Toolkit: Risk Measures And Visual Outputs To Support Health Technology Decision-making During Public Health Crises E Kirwin, C McCabe, J Round International Journal of Technology Assessment in Health Care 39 (S1), S12-S13, 2023 | | 2023 |
Influenza and Other Respiratory Infections: Healthcare costs and effects of post-COVID-19 condition in Canada E Rafferty, A Unsal, E Kirwin, U of Alberta, U of Manchester, U Kingdom Canada Communicable Disease Report 49 (10), 425, 2023 | | 2023 |
Coûts des soins de santé et effets du syndrome post-COVID-19 au Canada E Rafferty, A Unsal, E Kirwin RMTC 49 (10), 2023 | | 2023 |
Profiles in Epidemiology: Dr. Larry Svenson E Kirwin, S MacDonald, K Simmonds American Journal of Epidemiology 191 (4), 735-738, 2022 | | 2022 |
Health Technology Assessment Methods for Research Oriented Market Access E Kirwin, J Round, K Bond, G Hopkin, C McCabe 42nd Annual Meeting of the Society for Medical Decision Making, 2021 | | 2021 |